We are live on ! Find out more
ACM

Aster Capital Management Portfolio holdings

AUM $306M
1-Year Est. Return 18%
This Fund
S&P 500
This Quarter Est. Return
+2.68%
1 Year Est. Return
+18%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$262M
AUM Growth
-$200M
Cap. Flow
-$203M
Cap. Flow %
-77.33%
Top 10 Hldgs %
21.87%
Holding
1,620
New
546
Increased
210
Reduced
264
Closed
543

Sector Composition

Rank Sector Weight
1 Financials 18.24%
2 Technology 15.32%
3 Consumer Discretionary 10.57%
4 Industrials 9.06%
5 Communication Services 8.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXTR icon
851
Extreme Networks
EXTR
$3.43B
$5.22K ﹤0.01%
+312
New +$5.05K
ALEX
852
DELISTED
Alexander & Baldwin
ALEX
$5.22K ﹤0.01%
294
-88
-23% -$1.66K
UMH
853
UMH Properties
UMH
$1.29B
$5.19K ﹤0.01%
275
-317
-54% -$6.04K
RDW icon
854
Redwire
RDW
$2.56B
$5.15K ﹤0.01%
+313
New +$3.36K
IBRX icon
855
ImmunityBio
IBRX
$7.59B
$5.13K ﹤0.01%
+2,004
New +$8.35K
MRTN icon
856
Marten Transport
MRTN
$1.22B
$5.09K ﹤0.01%
326
-455
-58% -$7.58K
SMMT icon
857
Summit Therapeutics
SMMT
$10.8B
$5K ﹤0.01%
280
+83
+42% +$1.61K
ACHC icon
858
Acadia Healthcare
ACHC
$3B
$5K ﹤0.01%
+126
New +$5.68K
SOWG
859
Sow Good
SOWG
$68M
$4.98K ﹤0.01%
163
FLNC icon
860
Fluence Energy
FLNC
$1.89B
$4.89K ﹤0.01%
+308
New +$6.03K
VIAV icon
861
Viavi Solutions
VIAV
$9.6B
$4.86K ﹤0.01%
+481
New +$4.75K
VRE
862
DELISTED
Veris Residential
VRE
$4.81K ﹤0.01%
289
-231
-44% -$4.03K
CLDX icon
863
Celldex Therapeutics
CLDX
$3.22B
$4.8K ﹤0.01%
+190
New +$5.16K
FCPT icon
864
Four Corners Property Trust
FCPT
$2.77B
$4.75K ﹤0.01%
+175
New +$4.99K
DAKT icon
865
Daktronics
DAKT
$1.06B
$4.74K ﹤0.01%
+281
New +$4.24K
ETNB
866
DELISTED
89bio
ETNB
$4.71K ﹤0.01%
602
+490
+438% +$4.04K
IMVT icon
867
Immunovant
IMVT
$8.06B
$4.71K ﹤0.01%
190
-101
-35% -$2.87K
TVTX icon
868
Travere Therapeutics
TVTX
$5.84B
$4.69K ﹤0.01%
+269
New +$4.76K
EXAS
869
DELISTED
Exact Sciences
EXAS
$4.66K ﹤0.01%
83
-11,016
-99% -$686K
COGT icon
870
Cogent Biosciences
COGT
$7.22B
$4.64K ﹤0.01%
595
+482
+427% +$4.8K
TOST icon
871
Toast
TOST
$20.2B
$4.63K ﹤0.01%
+127
New +$4.46K
NRIX icon
872
Nurix Therapeutics
NRIX
$2.61B
$4.48K ﹤0.01%
+238
New +$5.46K
MYGN icon
873
Myriad Genetics
MYGN
$301M
$4.44K ﹤0.01%
324
-20,134
-98% -$372K
PTCT icon
874
PTC Therapeutics
PTCT
$5.78B
$4.42K ﹤0.01%
+98
New +$4.19K
VRNS icon
875
Varonis Systems
VRNS
$4.98B
$4.4K ﹤0.01%
+99
New +$5.15K

Similar funds

Aster Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Aster Capital Management held 1,620 positions worth $262M, down 43% from $462M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Aster Capital Management withdrew a net $203M in Q4 2024, closing 543 positions and reducing 264 holdings. Its most notable exit was Invesco QQQ Trust, an estimated $24.5M position sold in full.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 13% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Aster Capital Management opened a new position in iShares US Real Estate ETF worth $8.63M.

  • Aster Capital Management's largest Q4 2024 buy was iShares US Real Estate ETF: 92,707 shares worth $8.63M.
  • Aster Capital Management added most to Meta Platforms (Facebook) in Q4 2024, an estimated $8.47M increase.
  • Aster Capital Management's biggest Q4 2024 reduction was NVIDIA, cutting an estimated $11.6M.
  • Aster Capital Management fully exited Invesco QQQ Trust in Q4 2024, selling an estimated $24.5M.
  • Aster Capital Management's ten largest holdings make up 22% of its $262M portfolio in Q4 2024.
  • Aster Capital Management opened 546 new positions and closed 543 in Q4 2024.
  • Aster Capital Management's portfolio value fell 43% quarter-over-quarter to $262M.

Based on Aster Capital Management's 13F filing for Q4 2024, filed 13 Feb 2025.